3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Prostatic Neoplasms
3
Glioblastoma
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Osteonecrosis
1
Osteomyelitis
1
Neurodegenerative Diseases
1
Malignant Solid Neoplasm
1
Kidney Neoplasms
1
Ischemic Stroke
1
Hypoxia
1
Hemorrhagic Stroke
1
Head and Neck Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Chondrosarcoma
1
Childhood Brain Neoplasm
1
Central Nervous System Vascular Malformations
1
Central Nervous System Infections
1
Carcinoma, Medullary
1
Cancer of Lymph Node
1
Interventions
Ibandronic Acid
5
Zoledronic Acid
3
Denosumab
3
pembrolizumab
2
Sunitinib
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Methods
2
Interviews as Topic
2
Injections
2
Curettage
2
selinexor
1
saracatinib
1
ridaforolimus
1
radium Ra 223 dichloride
1
pegfilgrastim
1
olaparib
1
montanide ISA 51
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
endostar protein
1
cc-486
1
angiotensin I (1-7)
1
Vincristine
1
Transplantation, Homologous
1
Transplantation, Autologous
1
Transcranial Direct Current Stimulation
1
Trabectedin
1
Tomography, Spiral Computed
1
TES
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Bone Neoplasms
×
Ferrosoferric Oxide
×
Clear all
NCT01336803
2023-12-27
Osteosarcoma
Stanford University
Phase 2
Completed
32 enrolled
11 charts